Bayer: penalized by broker downgrade
Looking at the options for the German group, the broker considers that a separation from consumer healthcare 'may create value, but is not a short-term solution for the strained balance sheet', and believes that a separation from agrochemicals would destroy value.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction